Oncology Peer Review On-The-Go: Current Treatments in Peripheral T-cell Lymphoma

Podcast

Robert Stuver, MD, and Zachary D. Epstein-Peterson, MD, spoke with CancerNetwork® about a review article on the treatment of peripheral T-cell lymphoma published in the journal ONCOLOGY®.

Robert Stuver, MD, and Zachary D. Epstein-Peterson, MD, both of the Lymphoma Service in the Department of Medicine at Memorial Sloan Kettering Cancer Center in New York, spoke with CancerNetwork® about their review published in the journal ONCOLOGY® titled Current Treatment of Peripheral T-cell Lymphoma.

In the article, Stuver and Epstein-Peterson explored current approaches to the diagnosis and treatment of peripheral T-cell lymphoma and novel emerging strategies clinicians who are practicing in the community should be aware of.

Don’t forget to subscribe to the “Oncology Peer Review On-The-Go” podcast on Apple Podcasts, Spotify, or anywhere podcasts are available.

Recent Videos
Experts at Yale Cancer Center highlight ongoing trials intended to improve outcomes across mantle cell lymphoma, T-cell lymphoma, and other populations.
Non-Hodgkin lymphoma and other indolent forms of disease may require sequencing new treatments for years or decades, said Scott Huntington, MD, MPH, MSc.
A new clinical trial aims to offer a novel allogenic CAR T-cell product for patients with lymphoma closer to home.
Related Content